In contrast, IFNGR signaling in non-endothelial cells had the opposite effect of promoting tumor growth, consistent with the counter-regulatory production of IL6 elicited by IFNγ-mediated induction of IDO1. The gene discussed is IFNG; the disease is neoplasm.